Financials
Financial year 2024
Gross margin
€ 161
▼ 100% vs 2023
Profit
Caution€ -5,822
▼ 107% vs 2023
Debts
Normal€ 165,473
▼ 28% vs 2023
FirstPharma from Hove, company number BE0597961547, closed financial year 2024 with a result of € -5,822 after tax. For that financial year FirstPharma recorded a gross margin of € 161 and equity of € 39,767. Compared with financial year 2023, the result moved from € 81,200 to € -5,822. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
What happened at FirstPharma?
What happened at FirstPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 5,822 (▼ 107% vs 2023). filed late Source: NBB ↗
- New establishment in Hove. KBO
- Start of the company according to the CBE. KBO
- Alegria Comm. V. became a director. NBB
- Déjà Vu Comm. V. became a director. NBB
- Levante Comm V. became a director. NBB
- Salento Comm. V. became a director. NBB
In short
From € 117,225 loss in 2021 to € 5,822 loss in 2024.
Paid € 9,256 in corporate taxes since 2021.
Best year ever: 2022, with € 97,217 profit.
A new publication or filing at FirstPharma? We notify you, reason included.
Follow FirstPharmaNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind FirstPharma are Alegria Comm. V., Déjà Vu Comm. V., Levante Comm V. and Salento Comm. V.. The same people are also behind PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST, ANIMMO and ANTWERPS DISTRIBUTIE CENTRUM.
Directors
According to the 2024 annual accounts
Director · represented by Geert Van Genechten
Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST +4 more
since 2015
Director · represented by Koen Van Genechten
Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST +4 more
since 2015
Director · represented by Hilde Van Genechten
Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST +4 more
since 2015
Director · represented by Katleen Van Genechten
Also active at: PENELOPE-ANTWERPEN, Apotheek Antverpia, BRONKHORST +4 more
since 2015
Establishments
Establishment units
Physical locations of this company
Boechoutsesteenweg 17
2540 Hove
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0597.961.547
- VAT number
- BE 0597.961.547
- Registered office
- Boechoutsesteenweg 17, 2540 Hove
- Names & denominations
- FirstPharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 February 2015
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen
Overige niet-gespecialiseerde detailhandel
Overige detailhandel in voedingsmiddelen, neg
Detailhandel in cosmetica en toiletartikelen
Detailhandel via postorderbedrijven of via internet
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.